Silent Stroke During TAVR and Early Cognitive Impairment

Silent stroke is common after transcatheter aortic valve replacement (TAVR). Co-morbidities such as diabetes or chronic renal failure, as well as procedural factors such as pre-dilation, increase the risk of silent stroke.

Es un hecho: la protección cerebral en TAVI logró demostrar que reduce el stroke y la muerte

While many events of silent stroke have an early effect on cognition, it is necessary to learn whether the impairment is sustained over time—specially in lower-risk populations with longer life expectancy. Cerebral protection devices do not seem to significantly reduce the issue.

In this paper, a systematic search of every study reporting the incidence of silent cerebral lesions detected in post-TAVR diffusion MRI was conducted. The amount of new silent lesions, baseline characteristics of patients, and incidence of early cognitive impairment were evaluated.

A total of 39 studies with said characteristics were identified. They included over 2000 patients who met inclusion criteria and had undergone a diffusion MRI after TAVR.

Surprisingly, 1601 patients experienced at least one new silent cerebral lesion. However, the clinical significance of these new lesions only reached 3%.

The analysis of co-morbidities analysis showed that diabetes, chronic renal failure, evaluations with 3T equipment, and pre-dilation were associated with a higher risk of silent imaging.


Read also: Short Therapy and Monotherapy, Plenty of Evidence.


Prevalence of early cognitive impairment at one-year rose from 16% at 10.0 ± 6.3 days to 26% at 6.1 ± 1.7 months. The number of new silent cerebral lesions was also linked to early cognitive impairment, evidencing an association between the mean number of silent lesions and the incidence of impairment.

Using different cerebral protection devices during the procedure seems to reduce the number of lesions, but not the incidence of cognitive impairment.

Conclusion

Post-TAVR silent stroke is a common event. Co-morbidities such as diabetes and pre-dilation increase the chances of its occurrence.

While more new lesions negatively impact impairment, longer-term follow-up is needed to expand in younger populations. The use of brain protection devices does not seem to be clinically useful.

ehab002free

Original Title: Silent brain infarcts and early cognitive outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis.

Reference: Kei Woldendorp et al. European Heart Journal (2021) 42, 1004–1015 doi:10.1093/eurheartj/ehab002.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

1-Year Outcomes of US TAVR Registry with 5th Generation Balloon Expandable Valves

The use of transcatheter aortic valve replacement (TAVR) has extended to younger patients with lower risk severe aortic stenosis (AS) and therefore the improvement...

EuroSMR Registry: Edge-to-Edge Mitral Treatment with 5-Year Outcomes

Cardiomyopathies and left atrial enlargement can lead to secondary mitral regurgitation (SMR). This condition is associated with ventricular dysfunction, causing heart failure, hospitalization, and...

TricValve Transcatheter Bicaval Valve System for Severe Tricuspid Insufficiency: Events at One Year

TricValve is the first bicaval valve system to obtain CE-Mark approval. This device heterotopic device eliminates tricuspid insufficiency reflux into the venous system, reducing...

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

1-Year Outcomes of US TAVR Registry with 5th Generation Balloon Expandable Valves

The use of transcatheter aortic valve replacement (TAVR) has extended to younger patients with lower risk severe aortic stenosis (AS) and therefore the improvement...

EuroSMR Registry: Edge-to-Edge Mitral Treatment with 5-Year Outcomes

Cardiomyopathies and left atrial enlargement can lead to secondary mitral regurgitation (SMR). This condition is associated with ventricular dysfunction, causing heart failure, hospitalization, and...

TricValve Transcatheter Bicaval Valve System for Severe Tricuspid Insufficiency: Events at One Year

TricValve is the first bicaval valve system to obtain CE-Mark approval. This device heterotopic device eliminates tricuspid insufficiency reflux into the venous system, reducing...